First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

NCT03451370 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Elderly Metastatic Colorectal Cancer Patients

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Bevacizumab

Sponsor

Istituto Oncologico Veneto IRCCS